Corrigendum: Novel chemical scaffolds to inhibit the neutral amino acid transporter B&lt;sup&gt;0&lt;/sup&gt;AT1 (SLC6A19), a potential target to treat metabolic diseases. This evidence concerns the gene SLC6A19 and metabolic disease.